三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
r/rWM临床数据:泽布替尼vs伊布替尼(ASPEN研究)
r/rWM临床数据:泽布替尼vs伊布替尼(ASPEN研究)
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:102KB
图片尺寸:2302*859
同报告图片
/
4
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
所属报告:
百济神州-公司研究报告-生物科技出海明星2025年迎来蝶变-250622(30页).pdf
打包全文图表
相关数据
2020-2024年泽布替尼全球销售收入
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
收藏
行业数据
2025-08-25
原图定位
查看详情
R/RCLL最新PFS数据支持BGB-16673开展与匹妥布替尼的头对头试验
fCDpobnnm64gfCBCR0ItMTY2NzMgfCDljLnlronluIPmm7/lsLwgfAp8LS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLXwKfCBuICAgIHwgNjYgICAgICAgfCAxMTkgICAgICB8Cnwg5Lit5L2NUEZTLCDmnIggKDk1JSBDSSkgfCAyMi44ICgxNS42KSB8IDE0LjAgKDExLjItMTYuNikgfAp8IOS4reS9jemaj+iuv+aXtumXtCwg5pyIIHwgMTUuNiAgICAgIHwgMTkuNCAgICAgIHw=
收藏
行业数据
2025-08-07
原图定位
查看详情
CLL/SLLIII期临床安全性数据:泽布替尼降低心血管风险
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
收藏
行业数据
2025-08-07
原图定位
查看详情
无论IGHV突变状态如何,泽布替尼+索托克拉(左图)相比伊布替尼+维奈克
fCDnoJTnqbblkI3np7AgfCBJR0hW56qB5Y+YIHwgSUdIVuacqueqgeWPmCB8IOS4reS9jeaXtumXtO+8iOaciO+8iSB8CnwtLS0tLS0tLS0tLXwtLS0tLS0tLS0tfC0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS18CnwgQ0VMRVNUSUFMIDEwMSB8IDcuMiAgICAgIHwgNy4xICAgICAgICB8ICAgICAgICAgICAgfAp8IEZMQUlS56CU56m2ICAgfCAxOC4wICAgICB8IDExLjkgICAgICAgfCAgICAgICAgICAgIHw=
收藏
行业数据
2025-08-07
原图定位
查看详情
一线CLL/SLL诊疗指南:泽布替尼为首选推荐(PreferredRegiments)用药
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
收藏
行业数据
2025-08-07
原图定位
查看详情
一线CLL/SLL持续治疗方案III期临床数据(非头对头对比):泽布替尼展现同类最优潜力
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
收藏
行业数据
2025-08-07
原图定位
查看详情
BTK抑制剂全球销售额(百万美元):泽布替尼市场份额持续攀升
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
收藏
竞争格局
2025-08-07
原图定位
查看详情
2019Q4-2025Q1泽布替尼在中国、美国的销售额(单位:百万美元)
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
收藏
行业数据
2025-07-23
原图定位
查看详情
泽布替尼为同类最佳BTK抑制剂
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
收藏
行业数据
2025-04-18
原图定位
查看详情
泽布替尼美国/中国历年销售拆分
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
收藏
行业数据
2025-04-18
原图定位
查看详情
泽布替尼历年全球销售额/亿美元
fCDlubTku70gfCDplIDllK7pop3vvIjkur/nvo7lhYPvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18CnwgMjAyMCB8IDEgICAgICAgICAgICAgIHwKfCAyMDIxIHwgMyAgICAgICAgICAgICAgfAp8IDIwMjIgfCA2ICAgICAgICAgICAgICB8CnwgMjAyMyB8IDE0ICAgICAgICAgICAgIHwKfCAyMDI0IHwgMjYgICAgICAgICAgICAgfAoKCui1hOaWmeadpea6kO+8mmJpb1NlZWRpbu+8jOeZvua1juelnuW3nuWFrOS8l+WPt++8jOWbveebm+ivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-04-18
原图定位
查看详情
奥布替尼全球2期临床数据
fCDnu4TliKsgfCBBZGp1c3RlZCBtZWFuIGN1bXVsYXRpdmUgbnVtYmVyIG9mIG5ldyBsZXNpb25zIGJ5IHdrIDEyICg5NSUgQ0kpIHwgcOWAvCB8IE4gfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8CnwgUGxhY2VibyB8IDQuMzQgfCAtIHwgMjcgfAp8IE9yZWxhYnJ1dGluaWIgNTBtZyBRRCB8IDEuMTQgfCAwLjAyNzggfCAzMCB8CnwgT3JlbGFicnV0aW5pYiA1MG1nIEJJRCB8IDAuODIgfCAwLjAwNzMgfCAyOSB8CnwgT3JlbGFicnV0aW5pYiA4MG1nIFFEIHwgMC40MiB8IDAuMDAxOCB8IDI5IHw=
收藏
行业数据
2025-03-18
原图定位
查看详情
图13.泽布替尼在美国新增CLL患者中处方量排名第一
fCDlubTku70gfCDpmL/lj6/mm7/lsLwgfCDkvIrluIPmm7/lsLwgfCDms73luIPmm7/lsLwgfAp8LS0tLS0tfC0tLS0tLS0tfC0tLS0tLS0tfC0tLS0tLS0tfAp8IDIwMjEgfCA0MCUgICAgfCA2MCUgICAgfCAwJSAgICAgfAp8IDIwMjIgfCA1MCUgICAgfCA1NSUgICAgfCAxMCUgICAgfAp8IDIwMjMgfCA0NSUgICAgfCA0MCUgICAgfCA1MCUgICAgfAp8IDIwMjQgfCA0MCUgICAgfCAzNSUgICAgfCA2MCUgICAgfAoK6LWE5paZ5p2l5rqQ77ya55m+5rWO56We5bee77yMSFRJ
收藏
行业数据
2025-03-06
原图定位
查看详情
图14.泽布替尼在美国新增CLL患者中处方量排名第一
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
收藏
行业数据
2025-03-06
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
泽布替尼 WM数据优异。从泽布替尼 3 期头对头伊布替尼注册研究来看,泽布替尼单药治疗 r/r WM 的 42 个月 PFS 率为 78%,相对于伊布替尼的 HR 为 0.63。
行业数据
原图定位
当前图表所属:
百济神州-公司研究报告-生物科技出海明星2025年迎来蝶变-250622(30页).pdf
财务预测与估值
r/rWM临床数据:泽布替尼vs伊布替尼(ASPEN研究)
BTKi治疗r/rMCL临床数据对比
泽布替尼注册研究数据
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》